Impact of RAS mutation status on early progression in patients with initially unresectable colorectal liver metastases undergoing conversion therapy: a retrospective analysis - Quiz - MDSpire

Impact of RAS mutation status on early progression in patients with initially unresectable colorectal liver metastases undergoing conversion therapy: a retrospective analysis

  • By

  • Rong Yang

  • Weili Zhang

  • Jin Lan

  • Weihao Li

  • Zhigang Hong

  • Jun Chi

  • Jianhong Peng

  • Cong Li

  • Xiaojun Wu

  • July 1, 2026

  • 0 min

Share

Original Source(s)

Impact of RAS mutation status on early progression in patients with initially unresectable colorectal liver metastases undergoing conversion therapy: a retrospective analysis

  • by Rong Yang, Weili Zhang, Jin Lan, Weihao Li, Zhigang Hong, Jun Chi, Jianhong Peng, Cong Li, Xiaojun Wu

  • July 1, 2026

Related Content

Antibody-drug conjugates in colorectal cancer: current landscape and future perspectives from clinical trials

Surgeon workload in supervised robotic colorectal surgery: a surgical task load index study

Bifidobacterium infantis-mediated HSV-TK/GCV therapy modulates the tumor microenvironment through site-specific phosphorylation of HIF-1α, mTOR, and PD-L1